These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7769376)

  • 21. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
    Leung NW; Lai CL; Chang TT; Guan R; Lee CM; Ng KY; Lim SG; Wu PC; Dent JC; Edmundson S; Condreay LD; Chien RN;
    Hepatology; 2001 Jun; 33(6):1527-32. PubMed ID: 11391543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of hepatitis B surface antigen in patients with Down's syndrome.
    Yüksel M; Uzunalimoğlu O; Oge G; Demirağ B
    Turk J Pediatr; 1977; 19(1-2):47-51. PubMed ID: 154756
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea.
    Song BC; Suh DJ; Lee HC; Chung YH; Lee YS
    Hepatology; 2000 Oct; 32(4 Pt 1):803-6. PubMed ID: 11003626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hepatitis B e antigen in pregnant women and patients with liver disease.
    Gill HH; Majumdar PD; Dhunjibhoy KR; Desai HG
    J Assoc Physicians India; 1995 Apr; 43(4):247-8. PubMed ID: 8713262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleic acid sequence analysis of the precore region of hepatitis B virus from sera of southern African black adult carriers of the virus.
    Kramvis A; Bukofzer S; Kew MC; Song E
    Hepatology; 1997 Jan; 25(1):235-40. PubMed ID: 8985297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
    Kumar M; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW; Lee YC; Kim MS; Lee SY; Bae SH; Choi JY; Yoon SK
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
    Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
    J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of hepatitis B surface antigen (HBsAg) induced interleukin-2 secretion in chronic asymptomatic carriers of HBsAg.
    Sylvan SP; Hekkström UB
    Clin Exp Immunol; 1989 Nov; 78(2):207-13. PubMed ID: 12412750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B in a hospital for the mentally subnormal in South Wales.
    McGregor MA; Cowie VA; Wassef K; Veasey D; Munro J
    J Ment Defic Res; 1988 Feb; 32 ( Pt 1)():75-7. PubMed ID: 2966251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B.
    Vassilopoulos D; Rapti I; Nikolaou M; Hadziyannis E; Hadziyannis SJ
    J Viral Hepat; 2008 Nov; 15(11):817-26. PubMed ID: 18554242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP).
    Fattovich G; Giustina G; Realdi G; Corrocher R; Schalm SW
    Hepatology; 1997 Nov; 26(5):1338-42. PubMed ID: 9362381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B.
    Sokal EM; Kelly DA; Mizerski J; Badia IB; Areias JA; Schwarz KB; Vegnente A; Little NR; Gardener SD; Jonas MM
    Hepatology; 2006 Feb; 43(2):225-32. PubMed ID: 16440364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dealing with the patient carrying hepatitis B virus].
    Sasaki K; Watanabe T
    Kango Gijutsu; 1984 Sep; 30(12):1583-7. PubMed ID: 6566777
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.